Trial · NCT04333420
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Phase II: IFX-1 + BSC | 15 | |
| Overall Study | STARTED | Phase II: BSC | 15 | |
| Overall Study | STARTED | Phase III: IFX-1 + SOC | 178 | |
| Overall Study | STARTED | Phase III: Placebo + SOC | 191 | |
| Overall Study | Contributed to Full Analysis Set (FAS) | Phase II: IFX-1 + BSC | 15 | |
| Overall Study | Contributed to Full Analysis Set (FAS) | Phase II: BSC | 15 | |
| Overall Study | Contributed to Full Analysis Set (FAS) | Phase III: IFX-1 + SOC | 177 | |
| Overall Study | Contributed to Full Analysis Set (FAS) | Phase III: Placebo + SOC | 191 | |
| Overall Study | Contributed to Safety Analysis Set (SAF) | Phase II: IFX-1 + BSC | 15 | |
| Overall Study | Contributed to Safety Analysis Set (SAF) | Phase II: BSC | 15 | |
| Overall Study | Contributed to Safety Analysis Set (SAF) | Phase III: IFX-1 + SOC | 175 | |
| Overall Study | Contributed to Safety Analysis Set (SAF) | Phase III: Placebo + SOC | 189 | |
| Overall Study | COMPLETED | Phase II: IFX-1 + BSC | 13 | |
| Overall Study | COMPLETED | Phase II: BSC | 11 | |
| Overall Study | COMPLETED | Phase III: IFX-1 + SOC | 103 | |
| Overall Study | COMPLETED | Phase III: Placebo + SOC | 93 | |
| Overall Study | NOT COMPLETED | Phase II: IFX-1 + BSC | 2 | |
| Overall Study | NOT COMPLETED | Phase II: BSC | 4 | |
| Overall Study | NOT COMPLETED | Phase III: IFX-1 + SOC | 75 | |
| Overall Study | NOT COMPLETED | Phase III: Placebo + SOC | 98 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04333420/flow